BY MUNYARADZI BLESSING DOMA
The Medicines Control Authority of Zimbabwe (MCAZ) has issued a Class II recall of Torrent Captopril 25mg Tablets, Batch: B520K001, over quality concerns.
The medication which is used to manage high blood pressure (hypertension) and heart failure, is manufactured by Torrent Pharmaceuticals of India.
“This recall has been initiated following an Out-Of-Specification (OOS) result for Captopril disulfide (OOS No: OOS/BST/25/004), a key parameter in assessing product quality.
“Noncompliance with quality specifications may result in loss of efficacy and potential risk to patient safety,” said MCAZ Director General Richard Rukwata in a statement.
He added that they are calling on “all licensed pharmaceutical wholesalers, pharmacies, public and private clinics, and hospitals are to quarantine and discontinue the distribution of the affected batch immediately.
“Members of the public in possession of this product batch to return it to the pharmacy from which it was purchased or to the Authority.
“MCAZ is working closely with Torrent Pharmaceuticals Ltd and its local distributors to ensure the effective recall of the affected batch from the market.”
Rukwata added that Authority remains committed to ensuring the safety, quality and efficacy of all medicines available in Zimbabwe.
